Trial Profile

BuMA OCT Study(A Comparative Evaluation of BuMA Stent and of EXCEL Stent in Terms of the Extent of Neointima Formation at 3 Months After Implantation Using OCT)

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sirolimus (Primary) ; Antiplatelets
Indications Coronary artery disease; Coronary artery restenosis; Ischaemic heart disorders; Stent thrombosis; Unstable angina pectoris
Focus Therapeutic Use
Acronyms BuMA OCT
Sponsors SINO Medical Sciences Technology

Most Recent Events

10 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
01 Nov 2013 Status changed from not yet recruiting to active, no longer recruiting as per results presented at the 25th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
21 Jan 2013 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com